Lupin Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 15:59 Apr 29

2067.10

-38.30 (-1.82%)

84/100 High Financial Strength

Quality

35/100 Mid Valuation

Valuation

52/100 Technically Neutral

Technical

SWOT

Strength

Weakness

Opportunity

Threat

94.38K

Market Cap (Cr)

32.90

PE Ratio

6.03

Price to Book Ratio

53.36

RSI

9.56 %

Net Profit Margin

Rating Based on 9 Analysts

Buy 67%

Hold 22%

Sell 11%

Buy

The consensus recommendation from 6 analysts for Lupin Ltd. is Buy

Analyst Price Target

The average price target is 2329.44 with a high estimate of 2750 and low estimate of 1615

High Average Low

Current 2067.10

2750.00

2329.44

1615.00

Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation

SWOT

Strength Weakness Opportunity Threats

Recent Searches

Top Stocks

Lupin Ltd.

Lupin Ltd.

SWOT

94.38K

32.90

6.03

53.36

9.56 %

Rating Based on 9 Analysts

Analyst Price Target

SWOT

Download Our App On: